muscular dystrophy
Muscular dystrophy (MD) refers to a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Some forms of MD are seen in newborns, infants or children, while others have late-onset and may not appear until middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness (some forms of MD also affect cardiac muscle), age of onset, rate of progression, and pattern of inheritance. The prognosis for people with MD varies according to the type and progression of the disorder. There is no specific treatment to stop or reverse any form of MD. Treatment is supportive and may include physical therapy, respiratory therapy, speech therapy, orthopedic appliances used for support, corrective orthopedic surgery, and medicationsincluding corticosteroids, anticonvulsants (seizure medications), immunosuppressants, and antibiotics. Some individuals may need assisted ventilation to treat respiratory muscle weaknessor a pacemaker for cardiac (heart)abnormalities.
MONDO:0100167
pulmonary disease, chronic obstructive, susceptibility to
excluded_subClassOf
MONDO:0005336
myopathy
is_a
MONDO:0100546
hereditary neuromuscular disease
is_a
MONDO:0700223
hereditary skeletal muscle disorder
is_a
SPBC32H8.12c SPAC23C4.13 SPAPB1E7.09 SPBC1677.02 SPBP23A10.12 SPAC13D6.02c SPCC1235.16 SPBC26H8.07c SPCC63.13 SPCC1906.01 SPCC645.05c SPAC30C2.06c SPCC338.06c SPAC4A8.05c SPCC162.09c SPBC21B10.11 SPAC13G7.12c SPBC11G11.07 SPAC31A2.13c SPBC16C6.09 SPAC22A12.07c SPAC1A6.01c SPBC3E7.02c SPAC144.03 SPBC16E9.12c